Related Experiment Videos
Bladder augmentation in the pediatric age group
1Division of Urology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Insights
Enterocystoplasty is an effective treatment for pediatric bladder dysfunction. This bladder augmentation technique is safe and widely accepted, improving patient outcomes when combined with clean intermittent catheterization.
Area of Science:
- Pediatric Urology
- Surgical Innovation
Background:
- Vesical dysfunction in children presents complex management challenges.
- Traditional treatments have limitations, necessitating advanced surgical options.
Purpose of the Study:
- To evaluate the efficacy and safety of enterocystoplasty in managing pediatric vesical dysfunction.
- To highlight the importance of a multidisciplinary approach in long-term patient care.
Main Methods:
- Review of enterocystoplasty as a bladder augmentation procedure.
- Integration of clean intermittent catheterization (CIC) and antireflux mechanisms.
Main Results:
- Enterocystoplasty is an effective, safe, and useful addition to pediatric bladder dysfunction management.
- Increased acceptance due to the safety of CIC and effective antireflux strategies.
Conclusions:
- Enterocystoplasty is a valuable surgical option for pediatric bladder dysfunction.
- Surgeons require expertise in urodynamics and a commitment to lifelong patient management.
- Successful outcomes depend on managing primary disease and augmentation-specific needs.
Abstract:
In summary, enterocystoplasty has become an effective, safe and very useful addition to management of vesical dysfunction in children. The use of bladder augmentation has become more universally accepted with the recognition of the safety of clean intermittent catheterization and the development of efficient antireflux mechanisms when ureteral reimplantation into the bowel is required. However, the surgeon who wishes to participate in this endeavor must have a solid foundation and understanding of vesical urodynamics and must be committed to offering these children an ongoing program to manage their life-long problems associated with their primary disease as well as the special need associated with augmentation procedures.